Potential link between high FIB-4 score and chronic kidney disease in metabolically healthy men

Akihiro Kuma1,2, Kosuke Mafune3, Bungo Uchino4

  • 1Kidney Center, Hospital of the University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu, Fukuoka, 807-8556, Japan. kuma-aki@med.uoeh-u.ac.jp.

Scientific Reports
|October 5, 2022
PubMed

Insights

A high Fibrosis-4 (FIB-4) score may predict chronic kidney disease (CKD) development in metabolically healthy individuals. This score indicates liver fibrosis risk and was associated with CKD incidence and eGFR decline in non-obese, non-hypertensive, or non-smoking men.

Area of Science:

  • Nephrology
  • Hepatology
  • Epidemiology

Background:

  • Non-alcoholic fatty liver disease and chronic kidney disease (CKD) share known associations.
  • The predictive value of the Fibrosis-4 (FIB-4) score for incident CKD remains unclear.

Purpose of the Study:

  • To investigate whether the FIB-4 score predicts the development of CKD.
  • To analyze the association between FIB-4 score and CKD incidence over a 5-year period.

Main Methods:

  • Retrospective cohort study with 5-year follow-up data from Japanese health check-ups.
  • Exclusion of participants with existing CKD, alcohol consumption, and analysis of 5353 male participants.
  • Propensity score matching and multiple linear regression analysis to assess risk factors.

Main Results:

  • A high FIB-4 score (≥1.30) was not an independent risk factor for overall incident CKD.
  • However, a high FIB-4 score significantly predicted CKD in non-obese, non-hypertensive, or non-smoking participants.
  • High FIB-4 score strongly correlated with estimated glomerular filtration rate (eGFR) decline in these subgroups.

Conclusions:

  • The FIB-4 score may be a significant predictor of CKD incidence in metabolically healthy individuals.
  • This highlights a potential link between liver fibrosis markers and kidney health in specific populations.
  • Further research may elucidate the mechanisms underlying this association.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
57
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
36
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
71
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
146
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
64
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
44